Fidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Other Income Expense Net

Other Income/Expense Net for FBIOX.

Quarterly Other Income/Expense

-$4.48M

↓ 217.81% YoY

As of Sep 30, 2023

Annual Other Income/Expense (TTM)

-$9.64M

↑ 67.77% YoY

Trailing 12 months ending Sep 30, 2023

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin